Rephine has been awarded the prestigious ” Industry Partner of the Year” award for companies that work with or alongside generics and biosimilars manufacturers and suppliers. As the leading pharmaceutical consultancy, Rephine provides both GMP and GCP auditing services as well as a wide range of clinical and regulatory services to pharmaceutical, medical device and biotechnology industries worldwide.
Rephine’s unparalleled support to the pharmaceutical industry has led to the award at The 2019 Global Generics and Biosimilars. Nominees for this category were from industry partners such as; logistics providers, contract research organisations, contract-manufacturers, law firms and regulatory consultants.
Dr. Rino Coladangelo, CEO at Rephine says: “Rephine is extremely honoured to be named the Industry Partner of the Year. It brings the Rephine team and me a great amount of joy to see the organisation recognised by its peers for its continual support to the industry”
